Dr. Philip M Arlen, will be representing Precision Biologics in the
PLENARY KEYNOTE SESSION, PANEL DISCUSSION: Partnering and Licensing in
Immuno-Oncology at the  Cambridge Healthtech Institute’s 4th Annual
Neoantigen Targeted Therapies  Personalized Cancer Immunotherapy in
the Genomic Era August 8-9, 2019  at the Westin Boston Waterfront in
Boston, MA.

In addition, he will be delivering a lecture entitled ” Preliminary
First-in-Human Data with a Novel MAB, NEO 201, Targeting a Novel
Neoantigen in Solid Tumors” at this symposium. For more details, see
link below

http://www.giiconference.com/chi745206/neoantigen-targeted-therapies.shtml